Targeting the matrix: potential benefits for versican therapeutics

Mervyn J. Merrilees1 and Thomas N. Wight2,3biography
1The University of Auckland
2Benaroya Research Institute at Virginia Mason
3University of Washington

Versican is a chondroitin sulfate (CS) proteoglycan present in the interstitial space of all tissues and is notably elevated during early development, where it plays a key role in organogenesis, and later in numerous pathologies, often those affecting major organs such as vessels, lung and skin [1]. Accumulating evidence indicates that versican is of critical importance in chronic vascular diseases including atherosclerosis, aneurysms and restenosis [2]. Continue reading

Is losartan the drug for all seasons?

Francesco Ramirez1, and Daniel B Rifkin2biography
1Mount Sinai School of Medicine
2NYU School of Medicine, New York

Recent studies have raised the intriguing possibility that losartan, the prototypical angiotensin II (AngII) receptor type 1 (AT1r) blocker (ARB), should be used as a prophylactic drug akin to aspirin and statins. Other reports however have questioned whether losartan is the real thing or is this a case of unbridled enthusiasm fueling yet another bubble. While only time will tell, it is worth reviewing the pros and cons regarding losartan’s broad therapeutic potential. Continue reading

Glycosaminoglycans: From “cellular glue” to novel therapeutical agents

Nikos K. Karamanos1,2 and George N. Tzanakakis3 - biography
1University of Patras
2ICE-HT/FORTH
3University of Crete

Glycosaminoglycans (GAGs), linear macromolecular heteropolysaccharides consisting of disaccharide repeating units, are classified in several types. Hexuronic acid based GAGs include heparin and heparan sulfate (HS), which are glucosamine containing sulfated GAGs, chondroitin and dermatan sulphates (CS and DS), based on galactosamine, and hyaluronan which is a glucosamine based non-sulfated GAG.. Continue reading

Synthetic Heparin

Robert J. Linhardt1 and Jian Liu2 - biography
1Rensselaer Polytechnic Institute
2University of North Carolina

Heparin is a complex  polysaccharide-based anticoagulant drug that is essential for the practice of modern medicine [1]. Used in extracorporeal therapies, such as kidney dialysis, in the treatment of coagulation disorders, such as deep vein thrombosis (DVT), and to passivate the surfaces of indwelling devices, such as catheters, a heparin-based product is the first choice whenever blood clotting needs to be prevented or controlled. Continue reading

Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation

Liliana Schaefer1 and Renato V. Iozzo2 - biography
1Goethe University, Frankfurt, Germany,
2Thomas Jefferson University, Philadelphia, PA USA

Decorin and biglycan, the two best studied members of the small leucine-rich proteoglycan (SLRP) family, have been implicated in regulating cancer growth and inflammation, respectively. Decorin expression is almost always suppressed by cancer cells but abundantly produced by activated stromal fibroblasts in the tumor microenvironment [1]. Often an inverse relationship exists between cancer growth and decorin expression, suggesting that decorin is an “endogenous guardian” from the matrix. Continue reading

Massive overuse or appropriate medical intervention?
The modern-day use of antidepressants

David Nutt – biography
Imperial College London

Antidepressants have a peculiar place in the public mind. Almost every family in the UK will have someone taking these drugs; yet, the media are often very hostile to them with disparaging terms such as “happy pills” used to cast aspersions on their efficacy and utility [1]. Moreover, claims that they may cause suicidal ideation particularly in young people have lead to warning labels in the USA. Yet, despite the repeated media criticism, the use of antidepressants continues to be widespread. So what are the reasons for this? Continue reading